Vitalhub Corp. (TSE:VHI) Given Consensus Recommendation of “Buy” by Analysts

Vitalhub Corp. (TSE:VHI) has been given an average rating of “Buy” by the five ratings firms that are currently covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is C$11.60.

Several equities research analysts recently weighed in on VHI shares. Raymond James set a C$13.50 price target on shares of Vitalhub and gave the company an “outperform” rating in a research report on Thursday. Canaccord Genuity Group boosted their target price on Vitalhub from C$12.00 to C$12.50 and gave the stock a “buy” rating in a research report on Thursday, January 16th. Finally, Scotiabank set a C$14.00 price target on shares of Vitalhub and gave the company an “outperform” rating in a report on Thursday, January 30th.

Vitalhub Price Performance

Vitalhub stock traded up C$0.28 during mid-day trading on Thursday, reaching C$9.44. The stock had a trading volume of 79,644 shares, compared to its average volume of 143,892. Vitalhub has a one year low of C$5.80 and a one year high of C$12.09. The company has a 50-day moving average price of C$10.52 and a two-hundred day moving average price of C$10.31. The company has a market capitalization of C$510.63 million, a price-to-earnings ratio of 153.54, a PEG ratio of 1.18 and a beta of 1.26.

About Vitalhub

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.